Skip to main content

Table 1 Baseline characteristics in patients assigned to placebo, niacin 100 mg, and niacin 500 mg

From: A randomized pilot study on the effect of niacin on pulmonary arterial pressure

 

Placebo (n = 10)

Niacin 100 mg (n = 19)

Niacin 500 mg (n = 20)

Age (years)

69 ± 18.9

69 ± 15.5

67 ± 16.6

Male (N, %)

4 (40)

12 (63)

9 (45)

Hypertension (N, %)

6 (60)

12 (63)

16 (80)

Diabetes mellitus (N, %)

3 (30)

5 (26)

4 (20)

Hyperlipidemia (N, %)

1 (10)

3 (16)

4 (20)

COPD (N, %)

1 (10)

3 (16)

2 (10)

Smoker (N, %)

2 (20)

5 (26)

9 (45)

Left ventricular ejection fraction

56 ± 11.7 %

51 ± 13.3 %

56 ± 5.8 %

  1. COPD chronic obstructive pulmonary disease